We are live on ! Find out more
GGHC

Gilder Gagnon Howe & Co Portfolio holdings

AUM $9.69B
1-Year Est. Return 55.7%
This Fund
S&P 500
This Quarter Est. Return
+13.03%
1 Year Est. Return
+55.7%
3 Year Est. Return
+243.5%
5 Year Est. Return
+259.56%
10 Year Est. Return
+4,571.41%
AUM
$5.73B
AUM Growth
+$122M
Cap. Flow
-$305M
Cap. Flow %
-5.31%
Top 10 Hldgs %
36.62%
Holding
266
New
17
Increased
50
Reduced
179
Closed
19

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$54.5M
2
NVO
Novo Nordisk
NVO
+$53.8M
3
ABNB icon
Airbnb
ABNB
+$35.5M
4
BNTX icon
BioNTech
BNTX
+$22.3M
5
NVDA icon
NVIDIA
NVDA
+$16.9M

Sector Composition

Rank Sector Weight
1 Technology 32.17%
2 Consumer Discretionary 24.08%
3 Healthcare 19.02%
4 Industrials 8.18%
5 Communication Services 7.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BNTX icon
26
BioNTech
BNTX
$24.8B
$56.4M 0.98%
417,942
+145,658
+53% +$22.3M
ABNB icon
27
Airbnb
ABNB
$101B
$55M 0.96%
524,029
+320,706
+158% +$35.5M
TOST icon
28
Toast
TOST
$19.2B
$53.4M 0.93%
3,192,989
+177,797
+6% +$3.08M
NVDA icon
29
NVIDIA
NVDA
$5.09T
$52.4M 0.91%
4,317,310
+1,072,090
+33% +$16.9M
GOOG icon
30
Alphabet (Google) Class C
GOOG
$4.23T
$52.1M 0.91%
541,475
-278,205
-34% -$31.1M
DXCM icon
31
DexCom
DXCM
$31.3B
$51.4M 0.9%
638,785
-72,117
-10% -$6.11M
ENVX icon
32
Enovix
ENVX
$663M
$51.2M 0.89%
3,188,865
-62,704
-2% -$926K
ZM icon
33
Zoom
ZM
$27.8B
$50.4M 0.88%
685,499
-45,763
-6% -$4.36M
NVO
34
Novo Nordisk
NVO
$192B
$50M 0.87%
+1,004,430
New +$53.8M
DE icon
35
Deere & Co
DE
$182B
$49M 0.86%
146,757
-22,686
-13% -$7.77M
EPAM icon
36
EPAM Systems
EPAM
$6.38B
$48M 0.84%
132,543
+58
+0% +$22.2K
SNOW icon
37
Snowflake
SNOW
$117B
$47.1M 0.82%
277,253
-11,130
-4% -$1.84M
XYZ
38
Block Inc
XYZ
$47.8B
$46.8M 0.82%
851,090
-75,906
-8% -$5.37M
NYT icon
39
New York Times
NYT
$11.3B
$45.4M 0.79%
1,580,487
-6,758
-0.4% -$207K
MSFT icon
40
Microsoft
MSFT
$3.75T
$45.2M 0.79%
193,876
-29,428
-13% -$7.77M
SHOP icon
41
Shopify
SHOP
$172B
$43.9M 0.77%
1,627,858
-78,573
-5% -$2.67M
TRUP icon
42
Trupanion
TRUP
$1.09B
$43.6M 0.76%
734,392
-71,741
-9% -$4.82M
APPF icon
43
AppFolio
APPF
$7.86B
$41.6M 0.73%
397,340
-962
-0.2% -$98.1K
CRWD icon
44
CrowdStrike
CRWD
$241B
$40.9M 0.71%
992,124
+205,232
+26% +$9.39M
OPCH icon
45
Option Care Health
OPCH
$3.52B
$40.6M 0.71%
1,291,036
-1,475
-0.1% -$47.2K
SILV
46
DELISTED
SilverCrest Metals Inc. Common Shares
SILV
$40.5M 0.71%
7,319,194
-68,897
-0.9% -$407K
ROKU icon
47
Roku
ROKU
$23B
$36.3M 0.63%
643,511
-505,796
-44% -$38.5M
RGEN icon
48
Repligen
RGEN
$9.48B
$35.8M 0.63%
191,490
-28,093
-13% -$5.92M
DOCU
49
DocuSign
DOCU
$13B
$34.1M 0.59%
637,495
-20,655
-3% -$1.29M
GLOB icon
50
Globant
GLOB
$1.75B
$33.3M 0.58%
177,952
-32,178
-15% -$6.64M

Similar funds

Gilder Gagnon Howe & Co's Q3 2022 Portfolio in Review

As of Q3 2022, Gilder Gagnon Howe & Co held 266 positions worth $5.73B, up 2.2% from $5.61B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Gilder Gagnon Howe & Co withdrew a net $305M in Q3 2022, closing 19 positions and reducing 179 holdings. Its most notable exit was 1Life Healthcare, an estimated $23.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 33% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Gilder Gagnon Howe & Co opened a new position in Novo Nordisk worth $50M.

  • Gilder Gagnon Howe & Co's largest Q3 2022 buy was Novo Nordisk: 1,004,430 shares worth $50M.
  • Gilder Gagnon Howe & Co added most to Eli Lilly in Q3 2022, an estimated $54.5M increase.
  • Gilder Gagnon Howe & Co's biggest Q3 2022 reduction was Shockwave Medical, Inc. Common Stock, cutting an estimated $45.6M.
  • Gilder Gagnon Howe & Co fully exited 1Life Healthcare in Q3 2022, selling an estimated $23.4M.
  • Gilder Gagnon Howe & Co's ten largest holdings make up 37% of its $5.73B portfolio in Q3 2022.
  • Gilder Gagnon Howe & Co opened 17 new positions and closed 19 in Q3 2022.
  • Gilder Gagnon Howe & Co's portfolio value rose 2.2% quarter-over-quarter to $5.73B.

Based on Gilder Gagnon Howe & Co's 13F filing for Q3 2022, filed 14 Nov 2022.